Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Achilles Therapeutics PLC ADR stock

Learn how to easily invest in Achilles Therapeutics PLC ADR stock.

Achilles Therapeutics PLC ADR is a biotechnology business based in the US. Achilles Therapeutics PLC ADR shares (ACHL) are listed on the NASDAQ and all prices are listed in US Dollars. Achilles Therapeutics PLC ADR employs 234 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Achilles Therapeutics PLC ADR stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ACHL. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for all-in-one investing

M1 Finance

  • Commission-free stock and ETF trades
  • No management fees
  • Customizable portfolios with automatic rebalancing

Achilles Therapeutics PLC ADR stock price (NASDAQ: ACHL)

Use our graph to track the performance of ACHL stocks over time.

Achilles Therapeutics PLC ADR shares at a glance

Information last updated 2023-06-04.
Latest market close$1.02
52-week range$0.75 - $3.45
50-day moving average $0.93
200-day moving average $1.54
Wall St. target price$8.80
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.84

Buy Achilles Therapeutics PLC ADR stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
M1 Finance
Stocks, ETFs
Get $75 - $500
when you sign up and deposit min. $10,000 within 14 days. Terms and conditions apply
Build a custom portfolio of stocks and ETFs with automatic rebalancing.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency, Alternatives, Treasury Bills
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Earn a 5.4% yield with government-backed Treasury bills.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Achilles Therapeutics PLC ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Achilles Therapeutics PLC ADR price performance over time

Historical closes compared with the close of $1.0174 from 2023-06-02

1 week (2023-05-26) 0.63%
1 month (2023-05-05) 14.64%
3 months (2023-03-03) -4.93%
6 months (2022-12-05) -40.50%
1 year (2022-06-03) -58.98%
2 years (2021-06-04) -91.93%
3 years (2020-06-01) N/A
5 years (2018-06-01) N/A

Achilles Therapeutics PLC ADR financials

Gross profit TTM $0
Return on assets TTM -17.7%
Return on equity TTM -31.59%
Profit margin 0%
Book value $4.52
Market capitalisation $41.8 million

TTM: trailing 12 months

Achilles Therapeutics PLC ADR share dividends

We're not expecting Achilles Therapeutics PLC ADR to pay a dividend over the next 12 months.

Achilles Therapeutics PLC ADR share price volatility

Over the last 12 months, Achilles Therapeutics PLC ADR's shares have ranged in value from as little as $0.75 up to $3.45. A popular way to gauge a stock's volatility is its "beta".

ACHL.US volatility(beta: 0.93)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Achilles Therapeutics PLC ADR's is 0.9307. This would suggest that Achilles Therapeutics PLC ADR's shares are less volatile than average (for this exchange).

To put Achilles Therapeutics PLC ADR's beta into context you can compare it against those of similar companies.

Achilles Therapeutics PLC ADR overview

Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom. .

Frequently asked questions

What percentage of Achilles Therapeutics PLC ADR is owned by insiders or institutions?
Currently 5.963% of Achilles Therapeutics PLC ADR shares are held by insiders and 61.383% by institutions.
How many people work for Achilles Therapeutics PLC ADR?
Latest data suggests 234 work at Achilles Therapeutics PLC ADR.
When does the fiscal year end for Achilles Therapeutics PLC ADR?
Achilles Therapeutics PLC ADR's fiscal year ends in December.
Where is Achilles Therapeutics PLC ADR based?
Achilles Therapeutics PLC ADR's address is: 245 Hammersmith Road, London, United Kingdom, W6 8PW
What is Achilles Therapeutics PLC ADR's ISIN number?
Achilles Therapeutics PLC ADR's international securities identification number is: US00449L1026

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site